No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
WXXWY WUXI BIOLGCS ADR
- 3.250
- -0.030-0.91%
15min DelayClose Apr 24 16:00 ET
6.77BMarket Cap15.26P/E (TTM)
3.280High3.220Low78.06KVolume3.280Open3.280Pre Close252.35KTurnover0.00%Turnover Ratio15.26P/E (Static)2.08BShares13.25052wk High1.22P/B6.77BFloat Cap3.14052wk Low--Dividend TTM2.08BShs Float38.000Historical High--Div YieldTTM1.83%Amplitude3.140Historical Low3.232Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
On April 23, Yao Ming Biotech spent HK$24.884,200 to buy back 1.905 million shares
Pharmaceutical Biotech (02269) announced that on April 23, 2024, the company spent HK$24.884,200 to repurchase 1.905 million shares at a repurchase price of HK$12.92-13.32 per share.
Pharmaceutical Biotech (02269) spent HK$248.842 million to buy back 1.905 million shares on April 23
Yao Ming Biotech (02269) announced that on April 23, 2024, the company spent 24.8842 million...
On April 22, Yao Ming Biotech spent HK$1991215 million to buy back 1.55 million shares
Pharmaceutical Biotech (02269) announced that on April 22, 2024, it spent HK$1991215 million to repurchase 1.55 million shares.
Pharmaceutical Biotech (02269) spent HK$19912,150 to buy back 1.55 million shares on April 22
Pharmaceutical Biotech (02269) announced that on April 22, 2024, it cost HK$19912,150 to repurchase 15...
Pharmaceutical Biotech (02269.HK) spent HK$1992 million to buy back 1.57 million shares on April 19
Gelonghui, April 19 | Pharmaceutical Biotech (02269.HK) announced that it spent HK$19.92 million to buy back 1.57 million shares on April 19.
Trending Industry Today: GENSCRIPT BIO Leads Losses In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks
April 19th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(BK1261.HK)$ is trending lower today with 9 constituents down and GENSCRIPT BIO leading Losses.$GENS
Comments
JUST IN:
China's January to February industrial profit grew by 10.2% y/y to 0.914 trillion yuan.
NBS:
Revenue growth at industrial enterprises picked up markedly as market demand continued to recover and industrial output expanded rapidly, which created favorable conditions for their profits.
Some 29 out of China's 41 main industries saw profits rise in the first two months.
$Alibaba(BABA.US$$BABA-SW(09988.HK$$TENCENT(00700.HK$$XIAOMI-W(01810.HK$$JD-SW(09618.HK$$BIDU-SW(09888.HK$$BYD COMPANY(01211.HK$$SENSETIME-W(00020.HK$$China Petroleum & Chemical Corporation(600028.SH$
NBS:
Revenue growth at industrial enterprises picked up markedly as market demand continued to recover and industrial output expanded rapidly, which created favorable conditions for their profits.Some 29 out of China's 41 main industries saw profits rise in the first two months.$Alibaba(BABA.US$$BABA-SW(09988.HK$$TENCENT(00700.HK$$XIAOMI-W(01810.HK$$JD-SW(09618.HK$$BIDU-SW(09888.HK$$BYD COMPANY(01211.HK$$SENSETIME-W(00020.HK$$China Petroleum & Chemical Corporation(600028.SH$
2
Wuxi Biologics Earnings Report: FY Net Income Misses Estimates Despite Revenue Surpassing Predictions
Wuxi Biologics has reported a full-year net income of 3.40 billion yuan, falling short of the estimated 3.58 billion yuan.The company’s revenue exceeded estimates, coming in at 17.03 billion yuan against an estimated 16.98 billion yuan.Adjusted net income surpassed estimates, with Wuxi Biologics reporting 4.70 billion yuan against an estimated 4.2 billion yuan.The gross margin for the c... 2
HSI Closes at 16,473, Down 25 pts
At close, $Hang Seng Index(800000.HK$ dropped 25 pts or 0.2% to 16,473. $Hang Seng TECH Index(800700.HK$ dropped 18 pts or 0.5% to 3,437. $Hang Seng China Enterprises Index(800100.HK$ fell 3 pts or 0.1% to 5,754. Market turnover reached $112.71 billion.
Active Heavyweights:
$MEITUAN-W(03690.HK$ closed at $93.3, up 5.7%
$HKEX(00388.HK$ closed at $231.6, down 2.8%
$PING AN(02318.HK$ closed at $32.65, down 2.4%
$AIA(01299.HK$ closed at $54.8, down 2.1%
$BABA-SW(09988.HK$ closed at...
Active Heavyweights:
$MEITUAN-W(03690.HK$ closed at $93.3, up 5.7%
$HKEX(00388.HK$ closed at $231.6, down 2.8%
$PING AN(02318.HK$ closed at $32.65, down 2.4%
$AIA(01299.HK$ closed at $54.8, down 2.1%
$BABA-SW(09988.HK$ closed at...
2
2
$WUXI APPTEC(02359.HK$ closed up by 5.7% and $WUXI BIO(02269.HK$ rose by 7.5% in Hong Kong on Monday after the departure of Mike Gallagher, chairman of the House Select Committee on the Chinese Communist Party, which could slow the legislation’s progress of the Biosecure Act.
$Hang Seng H-Share Index ETF(02828.HK$$Hang Seng Index(800000.HK$
$Hang Seng H-Share Index ETF(02828.HK$$Hang Seng Index(800000.HK$
1
China's State Council on further foreign capital attractions:
To reduce the negative list for foreign investment access, expand the opening up for telecommunication and healthcare sectors, and scrap the negative list of manufacturing.To expand access to foreign financial institutions in the banking and insurance sectors.To expand the business scope for the domestic bond market, allow foreign financial institutions to underwrite onshore bonds.To expand pilot projects for Limited Partners... 6
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg